<DOC>
	<DOCNO>NCT01477957</DOCNO>
	<brief_summary>The purpose study : 1 . To explore extent insulin sensitivity , energy metabolism ectopic lipid storage improve bariatric surgery 2 . To explore extent hepatic muscular disorder energy metabolism occur patient obesity ( degree 2-3 ) 3 . To explore whether steato liver occur patient obesity ( degree 2-3 ) associate degree liver inflammation</brief_summary>
	<brief_title>The Effect Bariatric Surgery Insulin Sensitivity Energy Metabolism</brief_title>
	<detailed_description>Insulin resistance strongly relate ectopic lipid deposition skeletal muscle liver , correlate insulin resistance . Lipid metabolites accumulate skeletal muscle liver think impair insulin signal thereby reduce glucose uptake glycogen storage . Insulin resistant human frequently present decrease mitochondrial function skeletal muscle might contribute lipid accumulation development insulin resistance . Non-alcoholic liver disease ( NAFLD ) comprise fatty liver , steatohepatitis cirrhosis . NAFLD correlate insulin resistance increase risk cardiovascular disease , type 2 diabetes hepatocellular . The mechanisms lead fatty liver steatohepatitis insulin resistance liver yet unclear . Bariatric surgery relate surgery reduction body weight . Bariatric surgery frequently lead normalization glucose tolerance previously diabetic human even onset body weight reduction . The underlying mechanism yet unclear . In study aim explore mechanism underlie onset insulin resistance steatohepatitis patient fatty liver identify mechanism lead improve glucose tolerance human bariatric surgery . We test follow hypothesis : increase lipid availability lead ( ) increase lipid oxidation oxidative stress ( ii ) accumulation lipid metabolite impair insulin signalling ( iii ) bariatric surgery improve insulin sensitivity increase lipid oxidation . This study contribute understand NAFLD help identify new target therapy diabetes .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Aged ≥ 30 year ≤ 70 year Balanced sex ( 50 : 50 ) BMI 20 25 kg/m 2 normal weight group BMI 35 39,9 kg/m 2 ( Obese type II ) BMI &gt; 40 kg/m 2 ( Obese type III ) Acute illness 2 week start examination Autoimmune Immune disorder disease ( Leukozyten &lt; 5000/µl Renal insufficiency ( Kreatin &gt; 1,5 mg/dl ) Heart disease , condition heart attack Anemia ( Hb &lt; 12g/l , control every day examination ) blood donation 4weeks examination . Participation another trial within last 2 week Pharmacological immunotherapy ( Cortisol , Antihistaminika , ASS ) Thyroid disorder Glitazone Insulin Therapy Pregnancy , Lactation , Menstruation Smoking cigarette , Alcohol drug abuse Psychiatric disorder Risk for/ diagnose HIV/ AIDS Hepatitis B/C Liver disease , cause non alcoholic steato hepatitis Working night shift irregular rhythm night day Impaired wound heal clot disorder Allergic reaction local anesthetic Malignant cancer</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>weight loss bariatric surgery</keyword>
	<keyword>Insulin sensitivity</keyword>
	<keyword>insulin resistance</keyword>
</DOC>